Limited recovery from post-acute sequelae of SARS-CoV-2 at 8 months in a prospective cohort

David Ross Darley; Gregory John Dore; Anthony Luke Byrne; Marshall Lawrence Plit; Bruce James Brew; Anthony Kelleher; Gail Veronica Matthews

doi:10.1183/23120541.00384-2021

Limited recovery from post-acute sequelae of SARS-CoV-2 at 8 months in a prospective cohort

ERJ Open Res. 2021 Nov 1;7(4):00384-2021. doi: 10.1183/23120541.00384-2021. eCollection 2021 Oct.

Authors

David Ross Darley^{1

2}, Gregory John Dore^{3

4}, Anthony Luke Byrne^{1

2}, Marshall Lawrence Plit^{1

2}, Bruce James Brew^{2

5}, Anthony Kelleher^{4

6}, Gail Veronica Matthews^{3

4}

Affiliations

¹ Dept of Thoracic Medicine, St Vincent's Hospital Darlinghurst, Sydney, Australia.
² UNSW Medicine, St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
³ Dept of Infectious Diseases, St Vincent's Hospital Darlinghurst, Sydney, Australia.
⁴ Kirby Institute, University of New South Wales, Sydney, Australia.
⁵ Dept of Neurology and Peter Duncan Neurosciences Unit, St Vincent's Centre for Applied Medical Research, Sydney Australia.
⁶ Dept of Immunology, St Vincent's Hospital Darlinghurst, Sydney, Australia.

Abstract

In a longitudinal cohort, a significant proportion of patients had persistent symptoms 8 months after initial #COVID19 infection. There was no significant improvement in symptoms or health-related quality of life between 4- and 8-month assessments. https://bit.ly/2Wtb7IX.